<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01466101</url>
  </required_header>
  <id_info>
    <org_study_id>STU00025229</org_study_id>
    <nct_id>NCT01466101</nct_id>
  </id_info>
  <brief_title>Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy</brief_title>
  <official_title>Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pregabalin will decrease the total amount of opioid required in patients undergoing total
      abdominal hysterectomy. In addition, pregabalin will decrease the incidence of opioid-related
      side effects in patients undergoing total abdominal hysterectomy.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    PI left the institution. No subjects screened or enrolled.
  </why_stopped>
  <start_date>January 2011</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total hydromorphone consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>total hydromorphone consumption 24 hours post operatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores postoperative</measure>
    <time_frame>Post operative period</time_frame>
    <description>Post operative pain scores</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Pregabalin administration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration of pregabalin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Administration of placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo administration</intervention_name>
    <description>Administration of placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin administration</intervention_name>
    <description>Administration of pregabalin</description>
    <arm_group_label>Pregabalin administration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA Physical Status 1-2

          -  Age 18-64

          -  BMI 18-35

          -  Scheduled for elective total abdominal hysterectomy (with or without bilateral
             salpingo-oophorectomy)

          -  Gender: Female

          -  Consent: Obtained

        Exclusion Criteria:

          -  Patient refusal

          -  Allergy to study medication(s)

          -  Preoperative use of gabapentinoids

          -  Preoperative use of anticonvulsants

          -  Daily use of analgesics

          -  Hepatic disease

          -  Renal insufficiency (Cr &gt;2.0)

          -  Alcohol or drug abuse

          -  Pregnancy

          -  Language: Non-English speaking

          -  Patient expected to remain intubated after procedure

        Dropout:

          -  Patient request

          -  Surgeon request

          -  Allergic reaction to pregabalin

          -  Surgical procedure significantly altered from scheduled procedure
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Altman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <reference>
    <citation>Joshi GP. Multimodal analgesia techniques and postoperative rehabilitation. Anesthesiol Clin North America. 2005 Mar;23(1):185-202. Review.</citation>
    <PMID>15763418</PMID>
  </reference>
  <reference>
    <citation>Tang R, Evans H, Chaput A, Kim C. Multimodal analgesia for hip arthroplasty. Orthop Clin North Am. 2009 Jul;40(3):377-87. doi: 10.1016/j.ocl.2009.04.001. Review.</citation>
    <PMID>19576406</PMID>
  </reference>
  <reference>
    <citation>Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol. 2007 Oct;20(5):456-72. Review.</citation>
    <PMID>17873599</PMID>
  </reference>
  <reference>
    <citation>Turan A, Karamanlioğlu B, Memiş D, Usar P, Pamukçu Z, Türe M. The analgesic effects of gabapentin after total abdominal hysterectomy. Anesth Analg. 2004 May;98(5):1370-3, table of contents.</citation>
    <PMID>15105217</PMID>
  </reference>
  <reference>
    <citation>Gilron I, Orr E, Tu D, O'Neill JP, Zamora JE, Bell AC. A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy. Pain. 2005 Jan;113(1-2):191-200.</citation>
    <PMID>15621380</PMID>
  </reference>
  <reference>
    <citation>Jokela R, Ahonen J, Tallgren M, Haanpää M, Korttila K. A randomized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy. Pain. 2008 Jan;134(1-2):106-12. Epub 2007 May 15.</citation>
    <PMID>17507163</PMID>
  </reference>
  <reference>
    <citation>Jokela R, Ahonen J, Tallgren M, Haanpää M, Korttila K. Premedication with pregabalin 75 or 150 mg with ibuprofen to control pain after day-case gynaecological laparoscopic surgery. Br J Anaesth. 2008 Jun;100(6):834-40. doi: 10.1093/bja/aen098. Epub 2008 Apr 29.</citation>
    <PMID>18448418</PMID>
  </reference>
  <reference>
    <citation>Agarwal A, Gautam S, Gupta D, Agarwal S, Singh PK, Singh U. Evaluation of a single preoperative dose of pregabalin for attenuation of postoperative pain after laparoscopic cholecystectomy. Br J Anaesth. 2008 Nov;101(5):700-4. doi: 10.1093/bja/aen244. Epub 2008 Aug 20.</citation>
    <PMID>18716003</PMID>
  </reference>
  <reference>
    <citation>Cabrera Schulmeyer MC, de la Maza J, Ovalle C, Farias C, Vives I. Analgesic effects of a single preoperative dose of pregabalin after laparoscopic sleeve gastrectomy. Obes Surg. 2010 Dec;20(12):1678-81. doi: 10.1007/s11695-009-9944-1. Epub 2009 Aug 29.</citation>
    <PMID>19727980</PMID>
  </reference>
  <reference>
    <citation>Brandsborg B, Nikolajsen L, Hansen CT, Kehlet H, Jensen TS. Risk factors for chronic pain after hysterectomy: a nationwide questionnaire and database study. Anesthesiology. 2007 May;106(5):1003-12.</citation>
    <PMID>17457133</PMID>
  </reference>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2010</study_first_submitted>
  <study_first_submitted_qc>November 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2011</study_first_posted>
  <last_update_submitted>February 17, 2012</last_update_submitted>
  <last_update_submitted_qc>February 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Christian Altman</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hysterectomy</keyword>
  <keyword>Pain</keyword>
  <keyword>Pregabalin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

